Rice Hall James & Associates’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1,776,490	Closed	-$8.98M	–	289
2019 Q3	$8.98M	Sell	1,776,490 -466,013	-21%	-$2.32M	0.32%	105
2019 Q2	$13.8M	Sell	2,242,503 -50,676	-2%	-$244K	0.46%	87
2019 Q1	$10.6M	Buy	2,293,179 +369,680	+19%	+$1.67M	0.34%	101
2018 Q4	$8.08M	Buy	1,923,499 +578,239	+43%	+$2.94M	0.29%	106
2018 Q3	$8.44M	Sell	1,345,260 -44,580	-3%	-$342K	0.3%	100
2018 Q2	$11.2M	Buy	1,389,840 +15,378	+1%	+$117K	0.41%	85
2018 Q1	$10.3M	Sell	1,374,462 -7,945	-0.6%	-$52.8K	0.4%	91
2017 Q4	$8.22M	Buy	1,382,407 +67,464	+5%	+$410K	0.32%	97
2017 Q3	$9.68M	Sell	1,314,943 -49,936	-4%	-$317K	0.43%	91
2017 Q2	$9.27M	Buy	1,364,879 +266,763	+24%	+$1.97M	0.4%	91
2017 Q1	$10.4M	Sell	1,098,116 -14,702	-1%	-$147K	0.51%	82
2016 Q4	$9.62M	Sell	1,112,818 -16,301	-1%	-$120K	0.48%	84
2016 Q3	$7.15M	Buy	1,129,119 +164,322	+17%	+$993K	0.37%	91
2016 Q2	$4.07M	Buy	964,797 +44,906	+5%	+$217K	0.23%	94
2016 Q1	$4.01M	Buy	919,891 +28,219	+3%	+$126K	0.23%	96
2015 Q4	$5.47M	Buy	891,672 +409,618	+85%	+$2.69M	0.31%	87
2015 Q3	$2.76M	Buy	482,054 +421,104	+691%	+$3.23M	0.18%	127
2015 Q2	$455K	Buy	60,950 +7,953	+15%	+$48.1K	0.03%	272
2015 Q1	$317K	Buy	52,997 +27,633	+109%	+$174K	0.02%	294
2014 Q4	$192K	Buy	+25,364	New	+$152K	0.01%	299